The Union Cabinet has approved need-based sale of surplus land of four Pharmaceuticals PSUs to meet their outstanding liabilities. These PSUs are Hindustan Antibiotics Limited-HAL, Indian Drugs & Pharmaceuticals Limited-IDPL, Rajasthan Drugs and Pharmaceuticals Limited-RDPL and Bengal Chemicals and Pharmaceuticals Limited-BCPL.<br/> <br/>The sale will be done through open competitive bidding to government agencies and the outstanding liabilities will be met from sale proceeds. Voluntary Retirement Scheme and Voluntary Separation Scheme will also be implemented in these PSUs. After meeting the liabilities, steps will be taken to close IDPL and RDPL. The option of strategic sale will be explored for HAL and BCPL.